Series C - BillionToOne
Investment Firm
Overview
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Announced Date
Dec 15, 2022
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
8
Round Details and Background
BillionToOne raised $48500000 on 2022-12-15 in Series C
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 15, 2022 |  Series C - BillionToOne | 8 | - | 48.5M |
| Dec 15, 2022 | Debt Financing - BillionToOne | 1 | - | 35.0M |
| Jun 21, 2024 | Series D - BillionToOne | 8 | - | 130.0M |
| Sep 15, 2017 | Seed Round - BillionToOne | 8 | - | 2.4M |
Recent Activity
There is no recent news or activity for this profile.